Abstract
Significant progress has been made in the understanding of the neurohormonal factors that contribute to the progression of chronic renal and cardiac failure and the development of target-organ damage in patients with hypertension and diabetes. We herein review some of these advances, including a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with these disorders.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / physiopathology*
-
Humans
-
Kidney Diseases / drug therapy*
-
Kidney Diseases / physiopathology*
-
Natriuretic Peptides / physiology*
-
Protease Inhibitors / therapeutic use*
Substances
-
Natriuretic Peptides
-
Protease Inhibitors